CAS 68567-47-5

2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose

Produto Controlado

CAS: 68567-47-5

Applications 2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose is a glycopolymer located on the surface of cells that necessary in the immune response of a host. It influences biological functions and effect communication between different cells.
References Schmoelzer, C. et al.: Carb. Res., 367, 1 (2013);

Fórmula: C₁₀H₁₈N₂O₅

Cor e Forma: Neat

Peso molecular: 246.26

Ref: TR-B400155

2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose

CAS: 68567-47-5

2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose (BTDG) is a nitro derivative of L-threonine that has been derivatized with an acetyl group and a molecule of 2,4,6-trideoxygalactose. BTDG has been shown to be safe in clinical trials for vaccine development against life-threatening diseases. It is the first glycopolymer approved by the FDA for clinical use in humans. This drug has been shown to increase the antibody response and improve protection against influenza virus infection. BTDG also inhibits bacterial replication by blocking protein synthesis in some bacteria and inhibiting glycolysis in others.

Fórmula: C₁₀H₁₈N₂O₅

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 246.26 g/mol

Ref: 3D-MB167649